Brainsway Ltd Market Cap ($450.73 Million)
Market Cap & Net Worth: Brainsway Ltd (BWAY)
Brainsway Ltd market cap. Brainsway Ltd (NASDAQ:BWAY) has a market capitalization of $450.73 Million ($450.73 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #12509 globally and #3132 in its home market, demonstrating a -3.61% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Brainsway Ltd's stock price $11.21 by its total outstanding shares 40207981 (40.21 Million). Also see Brainsway Ltd cash flow conversion for how efficiently the company converts equity into cash flow.
Brainsway Ltd Market Cap History (2019–2026)
Brainsway Ltd market cap history from 2019 to 2026. Data shows growth from $392.03 Million to $450.73 Million (0.14% CAGR). Check Brainsway Ltd (BWAY) share price today for real-time trading data and today's change.
Index Memberships
Brainsway Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.02% | #340 of 976 |
|
NASDAQ Composite
IXIC
|
$40.12 Trillion | 0.00% | #1251 of 3165 |
Weight: Brainsway Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Brainsway Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Brainsway Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Brainsway Ltd equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
14.64x
Brainsway Ltd's market cap is 14.64 times its annual revenue
Latest Price to Earnings (P/E) Ratio
100.19x
Brainsway Ltd's market cap is 100.19 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $392.03 Million | $23.10 Million | -$10.33 Million | 16.97x | N/A |
| 2020 | $303.17 Million | $22.06 Million | -$5.38 Million | 13.74x | N/A |
| 2021 | $309.60 Million | $29.66 Million | -$6.46 Million | 10.44x | N/A |
| 2022 | $99.31 Million | $27.18 Million | -$13.35 Million | 3.65x | N/A |
| 2023 | $260.55 Million | $31.79 Million | -$4.20 Million | 8.20x | N/A |
| 2024 | $379.16 Million | $41.02 Million | $2.92 Million | 9.24x | 129.81x |
| 2025 | $764.76 Million | $52.23 Million | $7.63 Million | 14.64x | 100.19x |
Competitor Companies of BWAY by Market Capitalization
Companies near Brainsway Ltd in the global market cap rankings as of November 5, 2026. Also see Brainsway Ltd assets under control for a full breakdown of the balance sheet.
Key companies related to Brainsway Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #107 globally with a market cap of $196.11 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #182 globally with a market cap of $130.04 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #225 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #107 | Abbott Laboratories | NYSE:ABT | $196.11 Billion | $115.51 |
| #182 | Stryker Corporation | NYSE:SYK | $130.04 Billion | $339.65 |
| #225 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $104.96 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Brainsway Ltd (2019–2026)
Market capitalization of Brainsway Ltd from 2019 to today. Between 2019 and today, Brainsway Ltd's market cap moved from $392.03 Million to $ 450.73 Million, with a yearly change of 0.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $450.73 Million | -41.06% |
| 2025 | $764.76 Million | +101.70% |
| 2024 | $379.16 Million | +45.52% |
| 2023 | $260.55 Million | +162.35% |
| 2022 | $99.31 Million | -67.92% |
| 2021 | $309.60 Million | +2.12% |
| 2020 | $303.17 Million | -22.67% |
| 2019 | $392.03 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 5th, 2026 the market cap of Brainsway Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $450.73 Million USD |
| MoneyControl | $450.73 Million USD |
| MarketWatch | $450.73 Million USD |
| marketcap.company | $450.73 Million USD |
| Reuters | $450.73 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more